Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Microbiome in Cystic Fibrosis Pulmonary Disease
Alice Françoise, Geneviève Héry-Arnaud
Genes (2020) Vol. 11, Iss. 5, pp. 536-536
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
Caitlyn Harvey, Sinéad Weldon, J.S. Elborn, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3513-3513
Open Access | Times Cited: 39
Epithelial–Mesenchymal Transition Mechanisms in Chronic Airway Diseases: A Common Process to Target?
Angélique Mottais, Luca Riberi, Andrea Falco, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12412-12412
Open Access | Times Cited: 29
The mechanism of gut-lung axis in pulmonary fibrosis
Yawei Dong, Lanlan He, Zhongbo Zhu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 11
Direct Lung Sampling Indicates That Established Pathogens Dominate Early Infections in Children with Cystic Fibrosis
Peter Jorth, Zarmina Ehsan, Amir Akhavan Rezayat, et al.
Cell Reports (2019) Vol. 27, Iss. 4, pp. 1190-1204.e3
Open Access | Times Cited: 66
Impact of Altered Gut Microbiota and Its Metabolites in Cystic Fibrosis
Aravind Thavamani, Iman Salem, Thomas J. Sferra, et al.
Metabolites (2021) Vol. 11, Iss. 2, pp. 123-123
Open Access | Times Cited: 43
Gut Microbiome and Organ Fibrosis
Carolina F. F. A. Costa, Benedita Sampaio‐Maia, Ricardo Araújo, et al.
Nutrients (2022) Vol. 14, Iss. 2, pp. 352-352
Open Access | Times Cited: 36
Respiratory and Intestinal Microbiota in Pediatric Lung Diseases—Current Evidence of the Gut–Lung Axis
Sebastian Stricker, Torsten Hain, Cho‐Ming Chao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6791-6791
Open Access | Times Cited: 33
New Antimicrobial Strategies to Treat Multi-Drug Resistant Infections Caused by Gram-Negatives in Cystic Fibrosis
Viola Camilla Scoffone, Giulia Barbieri, Samuele Irudal, et al.
Antibiotics (2024) Vol. 13, Iss. 1, pp. 71-71
Open Access | Times Cited: 7
Next-Generation Sequencing Applications for the Study of Fungal Pathogens
Shiman Jiang, Yanfei Chen, Shengyi Han, et al.
Microorganisms (2022) Vol. 10, Iss. 10, pp. 1882-1882
Open Access | Times Cited: 26
Cystic fibrosis transmembrane conductance regulator in COPD: a role in respiratory epithelium and beyond
Marcus Mall, Gerard J. Criner, Marc Miravitlles, et al.
European Respiratory Journal (2022) Vol. 61, Iss. 4, pp. 2201307-2201307
Open Access | Times Cited: 23
Unmet challenges in cystic fibrosis treatment with modulators
Federica Corrao, Mairead Kelly, Isabelle Sermet‐Gaudelus, et al.
Expert Review of Respiratory Medicine (2024) Vol. 18, Iss. 3-4, pp. 145-157
Closed Access | Times Cited: 5
Spontaneous lung colonization in the cystic fibrosis rat model is linked to gastrointestinal obstruction
Mikayla Murphree-Terry, Johnathan D. Keith, Ashley M. Oden, et al.
mBio (2025)
Open Access
Role of RND Efflux Pumps in Drug Resistance of Cystic Fibrosis Pathogens
Viola Camilla Scoffone, Gabriele Trespidi, Giulia Barbieri, et al.
Antibiotics (2021) Vol. 10, Iss. 7, pp. 863-863
Open Access | Times Cited: 27
From ASCA breakthrough in Crohn's disease and Candida albicans research to thirty years of investigations about their meaning in human health
Boualem Sendid, Marjorie Cornu, Camille Cordier, et al.
Autoimmunity Reviews (2023) Vol. 23, Iss. 2, pp. 103486-103486
Open Access | Times Cited: 12
Interactions between Pseudomonas aeruginosa and six opportunistic pathogens cover a broad spectrum from mutualism to antagonism
Clémentine Laffont, Tobias Wechsler, Rolf Kümmerli
Environmental Microbiology Reports (2024) Vol. 16, Iss. 5
Open Access | Times Cited: 3
Untargeted Metagenomic Investigation of the Airway Microbiome of Cystic Fibrosis Patients with Moderate-Severe Lung Disease
Giovanni Bacci, Giovanni Taccetti, Daniela Dolce, et al.
Microorganisms (2020) Vol. 8, Iss. 7, pp. 1003-1003
Open Access | Times Cited: 26
The Multifaceted Roles of MicroRNAs in Cystic Fibrosis
Fatima Domenica Elisa De Palma, Valeria Raia, Guido Kroemer, et al.
Diagnostics (2020) Vol. 10, Iss. 12, pp. 1102-1102
Open Access | Times Cited: 24
Metaproteomics to Decipher CF Host-Microbiota Interactions: Overview, Challenges and Future Perspectives
P. Hardouin, R. Chiron, Hélène Marchandin, et al.
Genes (2021) Vol. 12, Iss. 6, pp. 892-892
Open Access | Times Cited: 21
Targeted Drug Delivery Technologies Potentiate the Overall Therapeutic Efficacy of an Indole Derivative in a Mouse Cystic Fibrosis Setting
Matteo Puccetti, Marilena Pariano, Giorgia Renga, et al.
Cells (2021) Vol. 10, Iss. 7, pp. 1601-1601
Open Access | Times Cited: 20
Impact of CFTR Modulators on the Impaired Function of Phagocytes in Cystic Fibrosis Lung Disease
Aniello Meoli, Olaf Eickmeier, Giovanna Pisi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12421-12421
Open Access | Times Cited: 15
Altered Ecology of the Respiratory Tract Microbiome and Nosocomial Pneumonia
Ana Elena Pérez‐Cobas, Fernando Baquero, Raúl de Pablo, et al.
Frontiers in Microbiology (2022) Vol. 12
Open Access | Times Cited: 14
Microbiota and fungal-bacterial interactions in the cystic fibrosis lung
Eneko Santos-Fernandez, Leire Martin–Souto, Aitziber Antoran, et al.
FEMS Microbiology Reviews (2023) Vol. 47, Iss. 3
Closed Access | Times Cited: 8
Emerging strategies to target virulence in Pseudomonas aeruginosa respiratory infections
Tegan M. Hibbert, Marvin Whiteley, Stephen A. Renshaw, et al.
Critical Reviews in Microbiology (2023), pp. 1-16
Open Access | Times Cited: 8
Sputum handling for rheology
Lydia Esteban Enjuto, Matthieu Robert de Saint Vincent, Max Maurin, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
The respiratory tract microbiome, the pathogen load, and clinical interventions define severity of bacterial pneumonia
Ana Elena Pérez‐Cobas, Christophe Ginévra, Christophe Rusniok, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 9, pp. 101167-101167
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top